Currently, ETP-ALL is defined by an immunoprofile that includes absence of CD1a, CD4 and CD8, low CD5 expression, and expression of one or more myeloid or stem cell antigens [1]. This evidence concerns the gene CD1A and acute lymphoblastic leukemia.